fellow
Vanderbilt University Medical Center
Nashville, TN, United States
Dr. Stephanie Rolsma is a third-year fellow in the Division of Pediatric Infectious Diseases at Monroe Carell Jr. Children’s Hospital at Vanderbilt.
Dr. Rolsma has experience in microbiology, vaccine development, and clinical research and her current research focuses on therapeutics and interventions in critically ill patients and clinical trials. Her primary research focuses on evaluating the utility of therapeutic drug monitoring of beta-lactam antibiotics in critically ill pediatric and adult patients, including patients receiving intensive cardiac support and renal replacement therapy. She also serves as a sub-investigator with her primary mentor, Dr. Buddy Creech, in studies conducted through the NIH-funded Vanderbilt Vaccine and Treatment Evaluation Unit (VTEU), including Moderna and Janssen Phase 3 SARS-CoV-2 vaccine trials in adults, a Moderna Phase 2/3 SARS-CoV-2 vaccine trial in children, a Moderna Phase 1 SARS-CoV-2 variant vaccine trial in adults, and a study of infant immune responses to RSV. She has successfully applied for fellowship funding support through the Childhood Infection Research Program NIH T32 Award and the David T. Karzon Fellowship in Pediatric Infectious Diseases.
Dr. Rolsma received her B.S. in Microbiology from Michigan State University. She was awarded a Ph.D. in Microbiology and Molecular Genetics and M.D. from the Medical College of Wisconsin, where she was a part of the Medical Scientist Training Program. She completed a residency in pediatrics at Monroe Carell Jr. Children’s Hospital at Vanderbilt prior to fellowship training.
I do not have any relevant financial / non-financial relationships with any proprietary interests.